特殊血液凝固检验市场:开发平台报告(开发阶段，市场区隔，地区·国家，法规途径，主要企业)，2023年最新版

本报告提供特殊血液凝固检验市场相关调查，提供产品概要与正在开发的开发中产品趋势，参与企业的最近趋势等资讯。

目录

第1章 目录

第3章 开发中的产品

• 特殊血液凝固检验- 各开发阶段的开发中产品
• 特殊血液凝固检验- 各地区的开发中产品
• 特殊血液凝固检验- 各法规途径的开发中产品
• 特殊血液凝固检验- 各估计核准日的开发中产品

第4章 特殊血液凝固检验- 企业正在开发的开发中产品

• 特殊血液凝固检验公司- 各开发阶段的开发中产品
• 特殊血液凝固检验- 各开发阶段的开发中产品

第5章 特殊血液凝固检验的企业与产品概要

• Diagnostica Stago Inc
• Helena Laboratories Corp
• Instrumentation Laboratory Co
• Massachusetts General Hospital
• Roche Diagnostics International Ltd
• Siemens Healthcare Diagnostics GmbH
• Siemens Healthcare Diagnostics Inc
• SQI Diagnostics Inc

第6章 特殊血液凝固检验- 最近的开发

第7章 附录

Abstract

GlobalData's Medical Devices sector report, "Special Coagulation Tests Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update" provides comprehensive information about the Special Coagulation Tests pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

These are reagents which are used to conduct special coagulation tests which provide quantitative determination of anticoagulant activities of heparin and thrombin formation.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

• Extensive coverage of the Special Coagulation Tests under development
• The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
• The report reviews the major players involved in the development of Special Coagulation Tests and list all their pipeline projects
• The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
• The report provides key clinical trial data of ongoing trials specific to pipeline products
• Recent developments in the segment / industry

Reasons to Buy

The report enables you to -

• Formulate significant competitor information, analysis, and insights to improve R&D strategies
• Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
• Identify and understand important and diverse types of Special Coagulation Tests under development
• Develop market-entry and market expansion strategies
• Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
• In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents

• 1.1 List of Tables
• 1.2 List of Figures

2 Introduction

• 2.1 Special Coagulation Tests Overview

3 Products under Development

• 3.1 Special Coagulation Tests - Pipeline Products by Stage of Development
• 3.2 Special Coagulation Tests - Pipeline Products by Territory
• 3.3 Special Coagulation Tests - Pipeline Products by Regulatory Path
• 3.4 Special Coagulation Tests - Pipeline Products by Estimated Approval Date

4 Special Coagulation Tests - Pipeline Products under Development by Companies

• 4.1 Special Coagulation Tests Companies - Pipeline Products by Stage of Development
• 4.2 Special Coagulation Tests - Pipeline Products by Stage of Development

5 Special Coagulation Tests Companies and Product Overview

• 5.1 Diagnostica Stago Inc Company Overview
  • 5.1.1 Diagnostica Stago Inc Pipeline Products & Ongoing Clinical Trials Overview
• 5.2 Helena Laboratories Corp Company Overview
  • 5.2.1 Helena Laboratories Corp Pipeline Products & Ongoing Clinical Trials Overview
• 5.3 Instrumentation Laboratory Co Company Overview
  • 5.3.1 Instrumentation Laboratory Co Pipeline Products & Ongoing Clinical Trials Overview
• 5.4 Massachusetts General Hospital Company Overview
  • 5.4.1 Massachusetts General Hospital Pipeline Products & Ongoing Clinical Trials Overview
• 5.5 Roche Diagnostics International Ltd Company Overview
  • 5.5.1 Roche Diagnostics International Ltd Pipeline Products & Ongoing Clinical Trials Overview
• 5.6 Siemens Healthcare Diagnostics GmbH Company Overview
  • 5.6.1 Siemens Healthcare Diagnostics GmbH Pipeline Products & Ongoing Clinical Trials Overview
• 5.7 Siemens Healthcare Diagnostics Inc Company Overview
  • 5.7.1 Siemens Healthcare Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
• 5.8 SQI Diagnostics Inc Company Overview
  • 5.8.1 SQI Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview

6 Special Coagulation Tests- Recent Developments

• 6.1 May 30, 2023: SQI Diagnostics reports second quarter 2023 results
• 6.2 Aug 29, 2022: SQI Diagnostics Reports Third Quarter 2022 Results
• 6.3 Jul 25, 2022: Beckman Coulter partners with Mass General and BARDA to identify severe pediatric infections in emergency departments

7 Appendix

• 7.1 Methodology
• 7.2 About GlobalData
• 7.3 Contact Us
• 7.4 Disclaimer

List of Tables

List of Tables

• Special Coagulation Tests - Pipeline Products by Stage of Development
• Special Coagulation Tests - Pipeline Products by Territory
• Special Coagulation Tests - Pipeline Products by Regulatory Path
• Special Coagulation Tests - Pipeline Products by Estimated Approval Date
• Special Coagulation Tests Companies - Pipeline Products by Stage of Development
• Special Coagulation Tests - Pipeline Products by Stage of Development
• Glossary

List of Figures

List of Figures

• Special Coagulation Tests - Pipeline Products by Stage of Development
• Special Coagulation Tests - Pipeline Products by Territory
• Special Coagulation Tests - Pipeline Products by Regulatory Path
• Special Coagulation Tests - Pipeline Products by Estimated Approval Date